Melanoma Institute of Australia’s Melanoma March returns

An Australian not-for-profit organisation is calling on Tasmanians to join its campaign to raise awareness and funds to combat one of the country’s biggest killers.

26 August 2020 – MPA Webinar Series

Event #1 – Wed 26th August from 7pm to 830pm Topics: Dermatology and Melanoma Surgery Please register via the Eventbrite link: https://www.eventbrite.com.au/e/dermatology-and-melanoma-surgery-a-discussion-with-our-specialists-registration-116189932215?aff=ebdssbeac >> DOWNLOAD PDF for full details

Melanoma survivors march to honour lost friends and raise awareness

Melanoma has a reputation for being one of the most curable types of cancers, but that does not mean much to survivors such as Jay Allen and Aaron Kelly.

Free skin checks for South West community

The Bunbury Skin Cancer Clinic is partnering with melanomaWA to provide the community with free skin checks on February 24.

Cancer in the News

Feature Articles

Melanoma Prevalence, Mortality Mostly Stable Over the Past 30 Years

Data from this new study suggest melanoma cases rose at a slower rate in lower-income countries, but the authors say that may be due to differences in case documentation.

READ MORE >

Posted in Melanoma News, Health Professionals, Of Interest

Patients present with later stage melanoma during COVID-19 pandemic

Many melanoma patients presented with more advanced disease during the COVID-19 pandemic, according to a small study published in the Journal of the American Academy of Dermatology.

READ MORE >

Posted in Melanoma News, Health Professionals, Of Interest

Sotigalimab Plus Nivolumab Shows Encouraging Activity in Anti–PD-1 Refractory Melanoma

The combination of sotigalimab (APX005M) and nivolumab (Opdivo) elicited durable responses with a reasonable safety profile in patients with melanoma who were refractory to anti–PD-1 therapy, according to data from a phase 2 trial (NCT03123783).

READ MORE >

Posted in Melanoma News, Health Professionals, Clinical Trials

What’s Ahead for Melanoma Management

Immunotherapy, intralesional treatments, multidisciplinary care teams define rapidly-evolving multimodal approach.

READ MORE >

Posted in Melanoma News, Health Professionals, Of Interest